Cargando…

CDKN2C-Null Leiomyosarcoma: A Novel, Genomically Distinct Class of TP53/RB1–Wild-Type Tumor With Frequent CIC Genomic Alterations and 1p/19q-Codeletion

PURPOSE: Leiomyosarcoma (LMS) harbors frequent mutations in TP53 and RB1 but few actionable genomic alterations. Here, we searched for recurrent actionable genomic alterations in LMS that occur in the absence of common untreatable oncogenic drivers. METHODS: Tissues from 276,645 unique advanced canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Erik A., Sharaf, Radwa, Decker, Brennan, Werth, Adrienne J., Toma, Helen, Montesion, Meagan, Sokol, Ethan S., Pavlick, Dean C., Shah, Nikunj, Williams, Kevin Jon, Venstrom, Jeffrey M., Alexander, Brian M., Ross, Jeffrey S., Albacker, Lee A., Lin, Douglas I., Ramkissoon, Shakti H., Elvin, Julia A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2020
Materias:	Original Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529542/ https://www.ncbi.nlm.nih.gov/pubmed/33015533 http://dx.doi.org/10.1200/PO.20.00040

Ejemplares similares

Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations
por: Williams, Erik A., et al.
Publicado: (2020)

Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles
por: Williams, Erik A., et al.
Publicado: (2020)

Vulvar Squamous Cell Carcinoma: Comprehensive Genomic Profiling of HPV+ Versus HPV– Forms Reveals Distinct Sets of Potentially Actionable Molecular Targets
por: Williams, Erik A., et al.
Publicado: (2020)

FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas
por: Sharaf, Radwa, et al.
Publicado: (2021)

Erratum to: FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas
por: Sharaf, Radwa, et al.
Publicado: (2021)

CYLD-mutant cylindroma-like basaloid carcinoma of the anus: a genetically and morphologically distinct class of HPV-related anal carcinoma
por: Williams, Erik A., et al.
Publicado: (2020)

Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma
por: Murugesan, Karthikeyan, et al.
Publicado: (2021)

CYLD mutation characterizes a subset of HPV-positive head and neck squamous cell carcinomas with distinctive genomics and frequent cylindroma-like histologic features
por: Williams, Erik A., et al.
Publicado: (2020)

A pan-cancer landscape of telomeric content shows that RAD21 and HGF alterations are associated with longer telomeres
por: Sharaf, Radwa, et al.
Publicado: (2022)

HPV51-associated Leiomyosarcoma: A Novel Class of TP53/RB1-Wildtype Tumor With Predilection for the Female Lower Reproductive Tract
por: Williams, Erik A., et al.
Publicado: (2022)

A pan-sarcoma landscape of telomeric content shows that alterations in RAD51B and GID4 are associated with higher telomeric content
por: Sharaf, Radwa, et al.
Publicado: (2023)

Pan-cancer landscape of CD274 (PD-L1) copy number changes in 244 584 patient samples and the correlation with PD-L1 protein expression
por: Huang, Richard S.P., et al.
Publicado: (2021)

Genomic landscape of non‐small‐cell lung cancer with methylthioadenosine phosphorylase (MTAP) deficiency
por: Ashok Kumar, Prashanth, et al.
Publicado: (2022)

Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic
por: Williams, Erik A., et al.
Publicado: (2020)

Genomic Profiling of Circulating Tumor DNA From Cerebrospinal Fluid to Guide Clinical Decision Making for Patients With Primary and Metastatic Brain Tumors
por: Ramkissoon, Lori A., et al.
Publicado: (2020)

Mutations in the TERC template sequence can be incorporated into the telomeres of human tumors
por: Sharaf, Radwa, et al.
Publicado: (2022)

Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion
por: García-Romero, Noemi, et al.
Publicado: (2020)

Comprehensive Genomic Profiling of 274 Thymic Epithelial Tumors Unveils Oncogenic Pathways and Predictive Biomarkers
por: Girard, Nicolas, et al.
Publicado: (2022)

JAK/STAT PATHWAY COOPERATES WITH CIC FUSIONS TO DRIVE CIC-REARRANGED SARCOMAS
por: Kaloti, R K, et al.
Publicado: (2023)

A case of CIC‐rearranged sarcoma with CIC‐LEUTX gene fusion in spinal cord
por: Song, Kun, et al.
Publicado: (2022)

Prevalence of High-Risk Nonvaccine Human Papillomavirus Types in Advanced Squamous Cell Carcinoma Among Individuals of African vs Non-African Ancestry
por: Williams, Erik A., et al.
Publicado: (2021)

Drivers of genomic loss of heterozygosity in leiomyosarcoma are distinct from carcinomas
por: Seligson, Nathan D., et al.
Publicado: (2022)

Variable Genomic Landscapes of Advanced Melanomas with Heavy Pigmentation
por: Huang, Richard S P, et al.
Publicado: (2022)

Designing and Programming CICS Applications
por: Horswill, John, et al.
Publicado: (2011)

Landscape of Biomarkers in Non-small Cell Lung Cancer Using Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry
por: Huang, Richard S. P., et al.
Publicado: (2021)

Pan-cancer analysis of the effect of biopsy site on tumor mutational burden observations
por: Papillon-Cavanagh, Simon, et al.
Publicado: (2021)

Pan-cancer landscape of CD274 (PD-L1) rearrangements in 283,050 patient samples, its correlation with PD-L1 protein expression, and immunotherapy response
por: Kelly, Andrew D, et al.
Publicado: (2021)

Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer
por: Sivapiragasam, Abirami, et al.
Publicado: (2020)

Integrative genomic and transcriptomic analysis of leiomyosarcoma
por: Chudasama, Priya, et al.
Publicado: (2018)

Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitors
por: Riess, Jonathan W., et al.
Publicado: (2021)

Expression of the CIC-DUX4 fusion oncoprotein mimics human CIC-rearranged sarcoma in genetically engineered mouse models
por: Hendrickson, Peter G., et al.
Publicado: (2023)

Expression of the CIC-DUX4 fusion oncoprotein mimics human CIC-rearranged sarcoma in genetically engineered mouse models
por: Hendrickson, Peter G., et al.
Publicado: (2023)

Association of CD274 (PD-L1) Copy Number Changes with Immune Checkpoint Inhibitor Clinical Benefit in Non-Squamous Non-Small Cell Lung Cancer
por: Murugesan, Karthikeyan, et al.
Publicado: (2022)

25 years of CIC – achievements and future goals
por: Gasteiger, Johann
Publicado: (2012)

Round cell sarcoma of the colon with CIC rearrangement
por: Maghrebi, H., et al.
Publicado: (2017)

CIC protein instability contributes to tumorigenesis in glioblastoma
por: Bunda, Severa, et al.
Publicado: (2019)

Primary Leptomeningeal Oligodendroglioma, IDH-Mutant, 1p/19q-Codeleted
por: Ballester, Leomar Y., et al.
Publicado: (2018)

Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic
por: Li, Yan-Xi, et al.
Publicado: (2016)

Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma
por: Bosnakovski, Darko, et al.
Publicado: (2021)

Clinically Advanced Pheochromocytomas and Paragangliomas: A Comprehensive Genomic Profiling Study
por: Bratslavsky, Gennady, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8rb30paf16mg0spdhnk4uomkcf